Sandbox Ochuko: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[ | '''Sticky platelet syndrome''' is a term used by some<ref name="pmid10548069">{{Cite journal|author=Mammen EF |title=Sticky platelet syndrome |journal=Semin. Thromb. Hemost. |volume=25 |issue=4 |pages=361–5 |year=1999 |pmid=10548069 |doi= 10.1055/s-2007-994939|url=}}</ref><ref name="pmid12627663">{{Cite journal|author=Frenkel EP, Mammen EF |title=Sticky platelet syndrome and thrombocythemia |journal=Hematol. Oncol. Clin. North Am. |volume=17 |issue=1 |pages=63–83 |date=February 2003 |pmid=12627663 |doi= 10.1016/S0889-8588(02)00096-5|url=}}</ref><ref name="pmid18662911">{{Cite journal|author=Mears KA, Van Stavern GP |title=Bilateral Simultaneous Anterior Ischaemic Optic Neuropathy Associated with Sticky Platelet Syndrome |journal=Br J Ophthalmol |volume= 93|issue= 7|pages= 885–6, 913|date=July 2008 |pmid=18662911 |doi=10.1136/bjo.2008.142919 |url=http://bjo.bmj.com/cgi/pmidlookup?view=long&pmid=18662911}}</ref><ref name="pmid2465231">{{Cite journal|author=Mammen EF, Barnhart MI, Selik NR, Gilroy J, Klepach GL |title="Sticky platelet syndrome": a congenital platelet abnormality predisposing to thrombosis? |journal=Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. |volume=115 |issue=3 |pages=361–5 |year=1988 |pmid=2465231 |doi= |url=}}</ref> to describe a disorder of [[platelet]] function.<ref name="pmid17532753">{{Cite journal|author=Mühlfeld AS, Ketteler M, Schwamborn K, ''et al'' |title=Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients |journal=Am. J. Transplant. |volume=7 |issue=7 |pages=1865–8 |date=July 2007 |pmid=17532753 |doi=10.1111/j.1600-6143.2007.01835.x}}</ref> It was first described by Mammen in 1983.<ref name="isbn0-521-83953-X">{{Cite book|author=Bick, Rodger L |title=Hematological complications in obstetrics, pregnancy, and gynecology |publisher=Cambridge University Press |location=Cambridge, UK |year=2006 |pages=147 |isbn=0-521-83953-X |oclc= |doi= |accessdate=}}</ref> It is inherited in an [[autosomal dominant]] pattern.<ref name="isbn0-521-87082-8">{{Cite book|author=McKay, Robert; David R. Gambling |title=Obstetric anesthesia and uncommon disorders |publisher=Cambridge University Press |location=Cambridge, UK |year=2008 |pages=308 |isbn=0-521-87082-8 |oclc= |doi= |accessdate=}}</ref> It has not been associated with a specific gene, and it is not recognized as an entity in [[OMIM]]. | ||
Among researchers using the term, it has been described as a coagulation disorder that can present in conjunction with [[protein S deficiency]] and [[Factor V Leiden]].<ref name="pmid9973658">{{Cite journal|author=Chaturvedi S, Dzieczkowski JS |title=Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes |journal=Cerebrovasc. Dis. |volume=9 |issue=2 |pages=127–30 |year=1999 |pmid=9973658 |doi= 10.1159/000015911|url=http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=ced09127}}</ref> It is not currently known if sticky platelet syndrome is a distinct condition, or if it represents part of the presentation of a more well characterized coagulation disorder. | |||
==Diagnosis== | |||
SPS is diagnosed by demonstrating platelet hyperaggregability. In a lab test called aggregometry platelet stickyness is stimulated with epinephrine (EPI) and/or adenosine diphosphate (ADP).<ref>http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1C-47T2D4S-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fa06922a824e24db83382664b8659e30</ref> This test is not possible for patients being treated with [[Aspirin|acetylsalicylic acid]] until that substance has sufficiently cleared from their system. | |||
==Treatment== | |||
Those diagnosed are usually treated with taking a low dose (80–100 mg) [[Aspirin]] a day.<ref>{{cite journal | pmid = 10548069 | doi=10.1055/s-2007-994939 | volume=25 | issue=4 | title=Sticky platelet syndrome | year=1999 | journal=Semin. Thromb. Hemost. | pages=361–5 | author=Mammen EF}}</ref> [[Anticoagulant]]s (e.g. [[Warfarin]], [[Coumadin]]) or clopidogrel ([[Plavix]]) are often additionally prescribed following formation of a medically significant clot. Thrombelastography is more commonly being used to diagnose hypercoagulability and monitor anti-platelet therapy. | |||
==Criticism== | |||
Critics of the diagnosis complain that case evidence is spotty and lacking controlled clinical studies.<ref>http://www.fvleiden.org/ask/78.html</ref> | |||
==References== | |||
{{Reflist|2}} | |||
Revision as of 17:36, 7 May 2015
Sticky platelet syndrome is a term used by some[1][2][3][4] to describe a disorder of platelet function.[5] It was first described by Mammen in 1983.[6] It is inherited in an autosomal dominant pattern.[7] It has not been associated with a specific gene, and it is not recognized as an entity in OMIM.
Among researchers using the term, it has been described as a coagulation disorder that can present in conjunction with protein S deficiency and Factor V Leiden.[8] It is not currently known if sticky platelet syndrome is a distinct condition, or if it represents part of the presentation of a more well characterized coagulation disorder.
Diagnosis
SPS is diagnosed by demonstrating platelet hyperaggregability. In a lab test called aggregometry platelet stickyness is stimulated with epinephrine (EPI) and/or adenosine diphosphate (ADP).[9] This test is not possible for patients being treated with acetylsalicylic acid until that substance has sufficiently cleared from their system.
Treatment
Those diagnosed are usually treated with taking a low dose (80–100 mg) Aspirin a day.[10] Anticoagulants (e.g. Warfarin, Coumadin) or clopidogrel (Plavix) are often additionally prescribed following formation of a medically significant clot. Thrombelastography is more commonly being used to diagnose hypercoagulability and monitor anti-platelet therapy.
Criticism
Critics of the diagnosis complain that case evidence is spotty and lacking controlled clinical studies.[11]
References
- ↑ Mammen EF (1999). "Sticky platelet syndrome". Semin. Thromb. Hemost. 25 (4): 361–5. doi:10.1055/s-2007-994939. PMID 10548069.
- ↑ Frenkel EP, Mammen EF (February 2003). "Sticky platelet syndrome and thrombocythemia". Hematol. Oncol. Clin. North Am. 17 (1): 63–83. doi:10.1016/S0889-8588(02)00096-5. PMID 12627663.
- ↑ Mears KA, Van Stavern GP (July 2008). "Bilateral Simultaneous Anterior Ischaemic Optic Neuropathy Associated with Sticky Platelet Syndrome". Br J Ophthalmol. 93 (7): 885–6, 913. doi:10.1136/bjo.2008.142919. PMID 18662911.
- ↑ Mammen EF, Barnhart MI, Selik NR, Gilroy J, Klepach GL (1988). ""Sticky platelet syndrome": a congenital platelet abnormality predisposing to thrombosis?". Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 115 (3): 361–5. PMID 2465231.
- ↑ Mühlfeld AS, Ketteler M, Schwamborn K; et al. (July 2007). "Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients". Am. J. Transplant. 7 (7): 1865–8. doi:10.1111/j.1600-6143.2007.01835.x. PMID 17532753.
- ↑ Bick, Rodger L (2006). Hematological complications in obstetrics, pregnancy, and gynecology. Cambridge, UK: Cambridge University Press. p. 147. ISBN 0-521-83953-X.
- ↑ McKay, Robert; David R. Gambling (2008). Obstetric anesthesia and uncommon disorders. Cambridge, UK: Cambridge University Press. p. 308. ISBN 0-521-87082-8.
- ↑ Chaturvedi S, Dzieczkowski JS (1999). "Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes". Cerebrovasc. Dis. 9 (2): 127–30. doi:10.1159/000015911. PMID 9973658.
- ↑ http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1C-47T2D4S-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fa06922a824e24db83382664b8659e30
- ↑ Mammen EF (1999). "Sticky platelet syndrome". Semin. Thromb. Hemost. 25 (4): 361–5. doi:10.1055/s-2007-994939. PMID 10548069.
- ↑ http://www.fvleiden.org/ask/78.html
Ventricular Tachycardia
Common causes of ventricular tachycardia include ischemic heart disease, illicit drugs (cocaine and methamphetamine), structural heart disease (including congenital heart diseases such as tetralogy of Fallot), inherited channelopathies, drug toxicity (digoxin, drugs that prolong the QT interval) and electrolyte disturbances (such as hypokalemia, hypomagnesemia, and hypocalcemia).
Table 1. Common Bacterial Pathogens in Neutropenic Patients |
---|
Gram-Positive Pathogens |
|
Gram-Negative Pathogens |
|
Bloodstream infections caused by endogenous flora and reactivation of latent infections account for a majority of initial febrile episode in neutropenic patients with cancer. Common bacterial isolates that cause bacteremia in the setting of neutropenia are listed in Table 1.[1] Certain endogenous microorganisms may be reactivated and exit latency during immunosuppression. These include herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, hepatitis B and C viruses, and Mycobacterium tuberculosis. Exogenous pathogens carried by contaminated blood products, medical equipment and devices, water sources, and health care workers represent less common sources of infection. These include Clostridium difficile, respiratory syncytial virus, vancomycin-resistant enterococci, and other multidrug resistant bacteria.[2]
Fungal infections often take place in the setting of prolonged or profound neutropenia after administration of empirical therapy. Candidiasis may range in severity from mucosal or cutaneous infection to septicemia, endocarditis, or disseminated infection. Aspergillus, on the contrary, typically causes life-threatening infection of the sinuses and lungs, particularly after protracted neutropenia.[3]
Causes by Organ System
Causes in Alphabetical Order
|
|
|
Causes of Hypotension
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Sandbox Ochuko developed by WikiDoc.org
Common Causes
- ACE inhibitors
- Addison's disease
- Alpha blockers
- Beta blockers
- Bleeding
- Calcium channel blockers
- Diabetes mellitus
- Diuretics
- Hypoglycemia
- Hypothermia
- Hypovolemia
- Pregnancy
- Sepsis
- Shock
- Tricyclic antidepressants
Sandbox Ochuko developed by WikiDoc.org
Causes by Organ System
Sandbox Ochuko developed by WikiDoc.org
Causes in Alphabetical Order
Sandbox Ochuko developed by WikiDoc.org
Primary treatment option Atropine
❑ Administer a first dose 0.5 mg IV bolus ❑ Repeat every 3-5 minutes ❑ Administer a maximum dose of 3 mg | |||||||||||||||||||
Secondary treatment options If atropine ineffective: ❑ Administer dopamine infusion (2-10 mcg/kg/min) OR ❑ Administer epinephrine infusion (2-10 mcg/min) OR ❑ Proceed with transcutaneous pacing | |||||||||||||||||||
❑ Consult a cardiologist ❑ Consider transvenous pacing | |||||||||||||||||||
- Adenine phosphoribosyltransferase deficiency
- Allopurinol
- Aniline
- Behcet's disease
- Benign prostatic hyperplasia
- Benzidine
- Bladder incontinence
- Bladder stones
- Bleomycin
- Candida
- Carbenicillin
- Cetirizine
- Chemical cystitis
- Chlamydia
- Chlordimeform
- Congenital abnormalities of the urinary tract
- Crohn's disease
- Cyclophosphamide
- Cystoscopy
- Danazol
- Dehydration
- Diabetes
- Diabetic neuropathy
- Diaphragm
- Diarrhea
- Diverticulitis
- Doxorubicin
- Drug induced cystitis
- Endometriosis
- Enterobacter
- Episiotomy scar infection
- Escherichia coli
- Ether
- Foreign body cystitis
- Gonorrhea
- Gynecological cancers
- Hemorrhagic cystitis
- Honeymoon cystitis
- Hunner's ulcer
- Ifosfamide
- Immobility
- Interstitial cystitis
- Intravesical acetic acid
- Kidney stones
- Klebsiella
- Lupus
- Methaqualone
- Methenamine mandelate
- Methicillin
- Methotrexate
- Mucoepithelial dysplasia, Witkop type
- Nonoxynol-9 suppositories
- NSAIDS
- Penicillin VK
- Penicillins
- PID
- Piperacillin
- Posterior urethral valves
- Prostatitis
- Pseudomonas aeruginosa
- Radiotherapy
- Schistosomiasis
- Serratia
- Sexually transmitted diseases
- Spermicidal jellies
- Spinal cord injury
- Staphylococcus saprophyticus
- Tampon
- Temozolomide
- Tiaprofenic acid
- Ticarcillin
- Toluidine
- Trichomoniasis
- Tuberculosis
- Urachal cancer
- Urachal cyst
- Urethral syndrome
- Urethritis
- Urinary catheter
- Urinary obstruction
- Urinary stones
- Urofacial syndrome
- Vesicoenteric fistula
- Xanthinuria
References
- ↑ Pagano, L. (2012-05). "A prospective survey of febrile events in hematological malignancies". Annals of Hematology. 91 (5): 767–774. doi:10.1007/s00277-011-1373-2. ISSN 1432-0584. PMID 22124621. Unknown parameter
|coauthors=
ignored (help); Check date values in:|date=
(help) - ↑ MD, John E. Niederhuber (2013-11-05). Abeloff's Clinical Oncology: Expert Consult Premium Edition - Enhanced Online Features and Print, 5e (5 edition ed.). Philadelphia, Pennsylvania: Saunders. ISBN 9781455728657. Unknown parameter
|coauthors=
ignored (help) - ↑ Freifeld, Alison G. (2011-02-15). "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 52 (4): 427–431. doi:10.1093/cid/ciq147. ISSN 1537-6591. PMID 21205990. Unknown parameter
|coauthors=
ignored (help)
Overview
Causes
Life Threatening Causes
Common Causes
Diagnosis
Focused Initial Rapid Evaluation
Complete Evaluation
A01 | |||||||||||||||||||||||||||||||||||||||||||||
B01 | |||||||||||||||||||||||||||||||||||||||||||||
C01 | |||||||||||||||||||||||||||||||||||||||||||||
D01 | D02 | ||||||||||||||||||||||||||||||||||||||||||||
E01 | E02 | ||||||||||||||||||||||||||||||||||||||||||||
F01 | |||||||||||||||||||||||||||||||||||||||||||||